Health data corpora

Longitudinal data.
Patient experience.

Define a cohort by condition, treatment, patient-reported measures and follow-up. RIDLY will assess scope, source coverage and permitted use before a licensing proposal.

8 corpus profiles
Cross-conditionFeasibility review

Longitudinal Health Journeys

Symptoms, medication use, daily functioning and personal health observations across conditions and time.

View corpus profile
ImmunologyFeasibility review

Autoimmune Longitudinal Data

Patient-reported flares, symptom burden, medication patterns and daily functioning for immune-mediated conditions.

View corpus profile
OncologyFeasibility review

Oncology Treatment & Patient Outcomes

Treatment journeys, symptom burden and patient-reported outcomes, with clinical and molecular context assessed by cohort.

View corpus profile
NeurologyFeasibility review

Neurological Symptoms & Treatment Response

Longitudinal symptoms, episode diaries, medication patterns and daily function for neurological conditions.

View corpus profile
DermatologyFeasibility review

Dermatology Symptoms & Treatment Response

Skin symptom reports, flares and treatment experience, with image and report coverage assessed separately.

View corpus profile
Metabolic healthFeasibility review

Metabolic & Cardiometabolic Outcomes

Medication use, health measurements and lifestyle observations for metabolic and cardiovascular outcome questions.

View corpus profile
Medication outcomesFeasibility review

Medication Safety & Adherence

Cross-condition medication histories, reported doses, missed doses and symptom observations over time.

View corpus profile
Mental healthFeasibility review

Mental Health & Daily Function

Mood, sleep, symptom patterns and daily functioning for longitudinal mental-health research questions.

View corpus profile
These profiles are open for feasibility inquiries, not immediate data delivery. Participant counts, geography, follow-up, field completeness and permitted uses are confirmed for each request.

Need a different population or combination of measures?

Specify your cohort criteria and intended use. Profiles can be assessed together without treating overlapping participants as separate people.

Discuss a custom corpus